Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma

NCT00049010 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

314

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

GENETIC: comparative genomic hybridization
GENETIC: cytogenetic analysis
GENETIC: fluorescence in situ hybridization
OTHER: immunohistochemistry staining method

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]